Wellness isn’t just about mindfulness, exercise, or the right skin routine. Science, politics, media
Omicron has now made landfall in the US. We are learning more about the variant every day—good, bad,
Because of an accident of history, we think of our teeth as being wholly separate from the rest of o
The movement to legalize cannabis has marked some major wins, helping us better understand its benef
Our health is inevitably tied to the health of our planet. At COP26, the world’s leaders tried to sa
Were we set up to fail? And how does our failure affect the most vulnerable people in society? Abdul
Decades of public health efforts turned America’s young people against smoking. And then JUUL made i
Coming to you LIVE from the American Public Health Association’s annual conference in Denver, Colora
CRISPR is one of those bio-scientific breakthroughs that has the potential to change society. Abdul
Densely-populated with lots of turn-over, cities are perhaps the worst place to be in a pandemic. An
PrEP — or “pre-exposure prophylaxis” — has been a game changer in HIV prevention, that is, for peopl
Abortion bans don’t stop abortions, they just make them less safe. Not only does Texas’s Draconian n
The COVID-19 vaccines have put the FDA front-and-center in our national COVID-19 response. Between t
Native American tribes were among the hardest hit by COVID-19, losing tribal elders to the virus—and
This week, we commemorate the 20th anniversary of September 11. The securitization at home and the “
As children head back to school, masks should be on the shopping list. But, despite CDC recommendati
As football season approaches, Abdul talks about his years on the field and his growing ambivalence
Nobody has come to represent the role of science in taking on this pandemic quite like Dr. Anthony F
Why is the delta variant a game-changer? Abdul dissects how the delta variant has changed our approa
We can’t talk about infrastructure without centering climate—and we can’t talk about climate without
Abdul dissects the FDA’s disastrous decision to approve the new Alzheimer’s drug aducanumab despite
